Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases.
- 1 September 1997
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 105 (suppl 5) , 1197-1203
- https://doi.org/10.1289/ehp.97105s51197
Abstract
Transforming growth factor beta (TGF-beta), a multifunctional cytokine and growth factor, plays a key role in scarring and fibrotic processes because of its ability to induce extracellular matrix proteins and modulate the growth and immune function of many cell types. These effects are important in inflammatory disorders with fibrosis and cancer. The asbestos-related diseases are characterized by fibrosis in the lower respiratory tract and pleura and increased occurrence of lung cancer and mesothelioma. We performed immunohistochemistry with isoform-specific antibodies to the three TGF-beta isoforms on 16 autopsy lungs from Quebec, Canada, asbestos miners and millers. There was increased immunolocalization of all three TGF-beta isoforms in the fibrotic lesions of asbestosis and pleural fibrosis. The hyperplastic type II pneumocytes contained all three isoforms. By contrast, there was differential spatial immunostaining for the TGF-beta isoforms in malignant mesothelioma, with TGF-beta 1 in the stroma but ...Keywords
This publication has 37 references indexed in Scilit:
- Transforming Growth Factors β1, β2, and β3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound HealingJournal of Biological Chemistry, 1996
- Transforming growth factor-beta 1 (TGF-β1)- and β2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancerClinical and Experimental Immunology, 1994
- Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats.Journal of Histochemistry & Cytochemistry, 1994
- Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disordersHistopathology, 1994
- Transforming Growth Factor-β: Expression in Normal and Pathological ConditionsHormone Research, 1994
- Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2Nature, 1992
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domainsCell, 1990
- Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.The Journal of Experimental Medicine, 1989
- Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.Journal of Clinical Investigation, 1987